Cargando…

Rescue of NBD2 Mutants N1303K and S1235R of CFTR by Small-Molecule Correctors and Transcomplementation

Although, the most common Cystic Fibrosis mutation, ΔF508, in the cystic fibrosis transmembrane regulator. (CFTR), is located in nucleotide binding domain (NBD1), disease-causing mutations also occur in NBD2. To provide information on potential therapeutic strategies for mutations in NBD2, we studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rapino, Daniele, Sabirzhanova, Inna, Lopes-Pacheco, Miquéias, Grover, Rahul, Guggino, William B., Cebotaru, Liudmila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370480/ https://www.ncbi.nlm.nih.gov/pubmed/25799511 http://dx.doi.org/10.1371/journal.pone.0119796

Ejemplares similares

Combination of Correctors Rescues CFTR Transmembrane-Domain Mutants by Mitigating their Interactions with Proteostasis
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2017)

Syntaxin 8 and the Endoplasmic Reticulum Processing of ΔF508-CFTR
por: Sabirzhanova, Inna, et al.
Publicado: (2018)

Correcting the Cystic Fibrosis Disease Mutant, A455E CFTR
por: Cebotaru, Liudmila, et al.
Publicado: (2014)

Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney Disease
por: Yanda, Murali K., et al.
Publicado: (2021)

Involvement of F1296 and N1303 of CFTR in induced-fit conformational change in response to ATP binding at NBD2
por: Szollosi, Andras, et al.
Publicado: (2010)

Bithiazole Correctors Rescue CFTR Mutants by Two Different Mechanisms
por: Loo, Tip W., et al.
Publicado: (2013)

NBD2 Is Required for the Rescue of Mutant F508del CFTR by a Thiazole-Based Molecule: A Class II Corrector for the Multi-Drug Therapy of Cystic Fibrosis
por: Brandas, Chiara, et al.
Publicado: (2021)

Extracellular phosphate enhances the function of F508del-CFTR rescued by CFTR correctors
por: Saint-Criq, Vinciane, et al.
Publicado: (2021)

Pharmacological Correctors of Mutant CFTR Mistrafficking
por: Pedemonte, Nicoletta, et al.
Publicado: (2012)

Functional Rescue of F508del-CFTR Using Small Molecule Correctors
por: Molinski, Steven, et al.
Publicado: (2012)

Novel CFTR modulator combinations maximise rescue of G85E and N1303K in rectal organoids
por: Ensinck, Marjolein M., et al.
Publicado: (2022)

Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
por: Capurro, Valeria, et al.
Publicado: (2021)

Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
por: Spanò, Virginia, et al.
Publicado: (2021)

Dexamethasone Regulates CFTR Expression in Calu-3 Cells with the Involvement of Chaperones HSP70 and HSP90
por: Prota, Luiz Felipe M., et al.
Publicado: (2012)

Stable ATP binding mediated by a partial NBD dimer of the CFTR chloride channel
por: Tsai, Ming-Feng, et al.
Publicado: (2010)

Nanomechanics combined with HDX reveals allosteric drug binding sites of CFTR NBD1
por: Padányi, Rita, et al.
Publicado: (2022)

Functional Transcomplementation between Wheat Dwarf Virus Strains in Wheat and Barley
por: Abt, Isabelle, et al.
Publicado: (2019)

Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors
por: Righetti, Giada, et al.
Publicado: (2020)

Syntaxin 6 and CAL Mediate the Degradation of the Cystic Fibrosis Transmembrane Conductance Regulator
por: Cheng, Jie, et al.
Publicado: (2010)

Discovery of a picomolar potency pharmacological corrector of the mutant CFTR chloride channel
por: Pedemonte, Nicoletta, et al.
Publicado: (2020)

Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
por: Renda, Mario, et al.
Publicado: (2023)

The NBD-NBD interface is not the sole determinant for transport in ABC transporters
por: Dönmez, Yaprak, et al.
Publicado: (2012)

Correctors modify the bicarbonate permeability of F508del-CFTR
por: Fiore, Michele, et al.
Publicado: (2020)

Cysteine accessibility probes timing and extent of NBD separation along the dimer interface in gating CFTR channels
por: Chaves, Luiz A. Poletto, et al.
Publicado: (2015)

Rescue of Mutant CFTR Trafficking Defect by the Investigational Compound MCG1516A
por: Lopes-Pacheco, Miquéias, et al.
Publicado: (2022)

Targeting protein–protein interactions to rescue Δf508-cftr: a novel corrector approach to treat cystic fibrosis
por: Devesa, Isabel, et al.
Publicado: (2013)

Rescue of multiple class II CFTR mutations by elexacaftor+tezacaftor+ivacaftor mediated in part by the dual activities of elexacaftor as both corrector and potentiator
por: Laselva, Onofrio, et al.
Publicado: (2021)

Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis
por: Graeber, Simon Y., et al.
Publicado: (2023)

Variable Responses to CFTR Correctors in vitro: Estimating the Design Effect in Precision Medicine
por: Matthes, Elizabeth, et al.
Publicado: (2018)

Lipid-driven CFTR clustering is impaired in cystic fibrosis and restored by corrector drugs
por: Abu-Arish, Asmahan, et al.
Publicado: (2022)

Computational Exploration of Potential CFTR Binding Sites for Type I Corrector Drugs
por: Lester, Anna, et al.
Publicado: (2023)

DNAJB12 and Hsp70 triage arrested intermediates of N1303K-CFTR for endoplasmic reticulum-associated autophagy
por: He, Lihua, et al.
Publicado: (2021)

Translating in vitro CFTR rescue into small molecule correctors for cystic fibrosis using the Library of Integrated Network‐based Cellular Signatures drug discovery platform
por: Strub, Matthew D., et al.
Publicado: (2021)

Disruption of the Unique ABCG-Family NBD:NBD Interface Impacts Both Drug Transport and ATP Hydrolysis
por: Kapoor, Parth, et al.
Publicado: (2020)

Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
por: Amico, Giulia, et al.
Publicado: (2019)

CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis
por: Lopes-Pacheco, Miquéias
Publicado: (2016)

Constrained Bithiazoles: Small Molecule Correctors of Defective ΔF508–CFTR Protein Trafficking
por: Coffman, Keith C., et al.
Publicado: (2014)

Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain
por: Odolczyk, Norbert, et al.
Publicado: (2013)

Combined Use of CFTR Correctors in LGMD2D Myotubes Improves Sarcoglycan Complex Recovery
por: Carotti, Marcello, et al.
Publicado: (2020)

CFTR corrector C17 is effective in muscular dystrophy, in vivo proof of concept in LGMDR3
por: Scano, Martina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1cjsjqvg5vgrk4tovn8fjqaj5a